Skip to main content
MAYNE PHARMA GROUP LIMITED logo

MAYNE PHARMA GROUP LIMITED — Investor Relations & Filings

Ticker · MYX ISIN · AU000000MYX0 LEI · 549300VIRDEN0N4MJG59 ASX Manufacturing
Open in API
Filings indexed 1,121 across all filing types
Latest filing 2012-10-18 Capital/Financing Update
Country AU Australia
Listing ASX MYX

About MAYNE PHARMA GROUP LIMITED

https://www.maynepharma.com

Mayne Pharma Group Limited is a specialty pharmaceutical company focused on the development and commercialization of branded and generic medicines. The company operates through specialized segments including Women's Health and Dermatology. Its Women's Health portfolio features innovative contraceptive solutions, while the Dermatology division provides a broad range of treatments for various skin conditions. Beyond its product portfolio, the company provides contract development and manufacturing services (CDMO), leveraging proprietary drug delivery technologies to produce complex oral and topical dosage forms. The organization focuses on high-growth specialty markets, aiming to deliver differentiated therapeutic options and improve patient outcomes through technical excellence and strategic commercialization.

Recent filings

Filing Released Lang Actions
Shareholder letter in respect of entitlement offer 1
Capital/Financing Update Classification · 95% confidence The document is a letter dated 19 October 2012 addressed to shareholders regarding a pro-rata accelerated non-renounceable retail entitlement offer by Mayne Pharma Group Limited. It discusses the details of the entitlement offer, application process, and the use of proceeds for an acquisition. The document is a communication about a capital raising event, specifically a share entitlement offer, rather than a full financial report or announcement of voting results. It does not contain financial statements or detailed financial analysis, nor is it a regulatory certification or a report publication announcement. The content fits the category of Capital/Financing Update as it provides information on the company's fundraising activity and capital structure changes through the entitlement offer.
2012-10-18 English
Becoming a substantial holder 3 pages 29.3KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 603 under Corporations Law Section 671B, titled 'Notice of initial substantial holder'. It details the substantial shareholding of Investors Mutual Limited in Mayne Pharma Ltd, including voting power, relevant interests, and consideration paid for shares. This type of filing is a notification of a major shareholding event, specifically the initial substantial holder notice. It is not an annual report, earnings release, or any other financial report. It fits the definition of a Major Shareholding Notification (MRQ). The document length and content confirm it is the actual notification, not just an announcement or certification.
2012-10-17 English
Section 708A notice 1 page 351.3KB
Share Issue/Capital Change Classification · 95% confidence The document is a notice under section 708A(5)(e) of the Corporations Act 2001 (Cth) regarding the issuance of fully paid ordinary shares by Mayne Pharma Group Limited. It details the issuance of shares under a placement and compliance with relevant sections of the Corporations Act. The content focuses on capital raising and share issuance without disclosure under Part 6D.2 of the Corporations Act. The document length is short (1595 characters) and is a formal announcement of a capital raising event, specifically the issuance of new shares. This fits the definition of a Share Issue/Capital Change announcement rather than a full financial report or other filing types. Therefore, the appropriate classification is Share Issue/Capital Change (SHA).
2012-10-16 English
Appendix 3B 9 pages 347.9KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 3B' and is an announcement related to a new issue of securities, specifically fully paid ordinary shares issued under an institutional placement and entitlement offer. It includes detailed information about the number of shares issued, issue price, purpose of the issue, underwriting details, and application for quotation of additional securities on the ASX. The document is a formal notification to the ASX about the issuance and quotation of new shares, consistent with regulatory requirements for capital raising announcements. It does not contain financial statements, management discussion, or audit information. It is not a full financial report but rather a capital/financing update regarding new share issuance and related details. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length (13,900 characters) supports that it is a substantive announcement rather than a brief notice or report publication announcement.
2012-10-16 English
Change in substantial holding 2 pages 100.6KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 Notice of change of interests of substantial holder under the Corporations Act 2001. It details changes in voting power and relevant interests of a substantial shareholder in Mayne Pharma Group Limited. This type of filing is a notification of changes in significant share ownership levels, which corresponds to a Major Shareholding Notification. The document is not a financial report, earnings release, or management report, but a regulatory filing specifically about shareholding changes.
2012-10-16 English
Ceasing to be a substantial holder 2 pages 90.3KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 605 under the Corporations Act 2001, titled 'Notice of ceasing to be a substantial holder.' It details changes in relevant interests and voting securities of a substantial shareholder, Dr Roger Aston, in Mayne Pharma Group Limited. This form is a regulatory notification about changes in significant share ownership levels, specifically ceasing to be a substantial holder. It is not a financial report, earnings release, or management report, but a formal notification of shareholding changes. Therefore, it fits the category of Major Shareholding Notification (MRQ). The document length and content confirm it is the actual notification, not just an announcement or certification.
2012-10-16 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.